LATEST BLOG

Top Biotech Performance Vs IBB Holdings

JT001

30-Jan-2018 07:19 AM

0

248

     The buyout of Juno Therapeutics (JUNO) and Bioverativ Inc (BIVV) has boosted the biotechnology sector.  With the tax reform, it only matter of time to see more acquisition down the road.. The iShares Nasdaq Biotechnology ETF (IBB:NASDAQ) and Spdr S&P Biotech Etf (XBI:NYSE) Year-To-Date up 10.99% and 14.33%, respectively. These are the current biotech best performance that helped the ETFs. Data as of Jan 29, 2018 close. 

  • Atara Biotherapeutics Inc (ATRA:NASDAQ)
  • CRISPR Therapeutics AG (CRSP:NASDAQ)
  • Global Blood Therapeutics Inc (GBT:NASDAQ)
  • Enanta Pharmaceuticals Inc (ENTA:NASDAQ)
  • Agio Pharmaceuticals Inc (AGIO:NASDAQ)

Here a look at IBB top holdings performance:

Contact us:

Twitter: @BiotechMoney18

Email: JT@TradersFish.com

            Support@TradersFish.com

Add Your Comment


TradersFish provides FREE valuable, unique, and simplified stock market data. Your donation will help us further expand our operations. Thank you for your contribution!


Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that TradersFish.com will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.